Lipid levels can remain controlled with electronic laboratory reminder letters for most patients with coronary artery disease discharged from a cardiovascular disease management program.
for the Clinical Pharmacy Cardiac Risk Service Study Group
Advertisement
Articles by for the Clinical Pharmacy Cardiac Risk Service Study Group
Advertisement
Latest Updated Articles
- Outcomes of Patients Discharged From Pharmacy-Managed Cardiovascular Disease Management
Published: August 7th 2009 | Updated:
- Angiotensin-converting Enzyme Inhibitor Therapy for Coronary Artery Disease and Diabetes Mellitus
Published: October 1st 2007 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
3
How Clinician-Led Partnerships Strengthen Post-Acute Care
4
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
5
